NEW YORK (GenomeWeb) – OneOme announced today that it has partnered with Total Quality Medicine (TQM) to offer its pharmacogenomic testing and support services in Mexico.

Under the terms of the deal, OneOme's PCR-based RightMed genetic test — which covers 22 genes in which variants are known to contribute to the effectiveness or safety of more than 340 drugs for more than 20 indications — will be incorporated into Mexico City-based TQM's GeneTest line of personalized medicine products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.